The threat from the pink corner

被引:80
作者
Livermore, DM [1 ]
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
关键词
Acinetobacter; antibiotic resistance; beta-lactamase; gram-negative bacteria; metallo-beta-lactamases; multi-resistance; Pseudomonas;
D O I
10.1080/07853890310001609
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In terms of numbers of isolates, the greatest present resistance problems arise with gram-positive pathogens (which stain purple/black in Gram's method). especially methicillin-resistant Staphylococcus aureus (MRSA). But, is the MRSA problem - by its size - blinding us to something ultimately more dangerous: the slow emergence of gram-negative pathogens (which stain pink) with resistance to all reliable antibiotics? Although presently rare,'pan-resistant' gram-negative bacteria - predominantly strains of Pseudomonas aeruginosa and Acinetobacter baumannii- have more comprehensive resistance than any gram-positive pathogen. They already pose treatment problems in compromised hospital patients, especially in specialist units, as well in particular groups, such as cystic fibrosis patents. Disturbingly, there is a near-total lack of developmental antibiotics active against gram-negative pathogens.
引用
收藏
页码:226 / 234
页数:9
相关论文
共 55 条
  • [31] Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
    Levin, AS
    Barone, AA
    Penço, J
    Santos, MV
    Marinho, IS
    Arruda, EAG
    Manrique, EI
    Costa, SF
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) : 1008 - 1011
  • [32] Livermore David M, 2002, Curr Opin Investig Drugs, V3, P218
  • [33] Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:: Our worst nightmare?
    Livermore, DM
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) : 634 - 640
  • [34] LIVERMORE DM, 2003, IN PRESS INT J ANTIM
  • [35] Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:: Novel agents for combination therapy
    Lomovskaya, O
    Warren, MS
    Lee, A
    Galazzo, J
    Fronko, R
    Lee, M
    Blais, J
    Cho, D
    Chamberland, S
    Renau, T
    Leger, R
    Hecker, S
    Watkins, W
    Hoshino, K
    Ishida, H
    Lee, VJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 105 - 116
  • [36] Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain
    Lopez-Otsoa, F
    Gallego, L
    Towner, KJ
    Tysall, L
    Woodford, N
    Livermore, DM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (12) : 4741 - 4743
  • [37] Efficacy of colistin versus β-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii
    Montero, A
    Ariza, J
    Corbella, X
    Doménech, A
    Cabellos, C
    Ayats, J
    Tubau, F
    Ardanuy, C
    Gudiol, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1946 - 1952
  • [38] Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei
    Moore, RA
    DeShazer, D
    Reckseidler, S
    Weissman, A
    Woods, DE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (03) : 465 - 470
  • [39] Cloning of the class D β-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains
    Niumsup, P
    Wuthiekanun, V
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (04) : 445 - 455
  • [40] Emerging carbapenemases in Gram-negative aerobes
    Nordmann, P
    Poirel, L
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (06) : 321 - 331